Business
Press Release Sep 04 2023
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated September 04, 2023, titled "Press Release regarding our Subsidiary Caplin Steriles Limited, which has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA).".
About this update from Caplin Point Laboratories Limited
[{"type":"text","content":" Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated September 04, 2023, titled \"Press Release regarding our Subsidiary Caplin Steriles Limited, which has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA).\". View Attachment","length":471,"tagName":"div"}]